Titan America SA Common Shares (TTAM)
14.70
+0.23 (1.59%)
NYSE · Last Trade: Aug 8th, 3:42 AM EDT

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025